Published 2 days ago • loading... • Updated 23 hours ago

The Future of Gene Therapies and Their Impact on Payers

Summary by Managed Healthcare Executive

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review (ICER) addresses the possible gene therapies that we could see reach the market this year.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

BioBridge Global

Build Resilience for Advanced Therapies with Supply Chain and Resource Planning - BioBridge Global

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally published on LinkedIn on March 25, 2025 You might agree that every therapy’s promise relies not only on great science but also on the ability to deliver it, safely, reliably, and at scale. In cell and gene therapy, where starting materials can be perishable and perso…

23 hours ago

Read Full Article